The UK has been on a losing streak for too long. But the clouds seem to be lifting and Britons are beginning to win again.

Rare disease and gene therapy stocks, battered in recent months by clinical and commercial setbacks, will likely benefit from the sudden departure this past week of Vinayak (Vinay) Prasad, MD, as ...